TickerFacts.

Company research / ISCO

International Stem Cell CORP (ISCO)

Build a valuation ↗↓ Download CSV

CIK 0001355790 · OTC · Pharmaceutical Preparations

  • Sector Manufacturing
  • Incorporated DE
  • Fiscal year ends Dec 31

For the year ended 2025-12-31, International Stem Cell CORP reported revenue of $9.10M. Revenue grew 0.2% from the prior annual period.

Key ratios (year ended 2025-12-31)

-2.9%
Operating margin
-4.6%
Net margin
0.2%
Revenue growth (YoY)

Beyond the statements

Follow the company.

Explore new filings, reported insider transactions and company relationships.

Open company research ↗

Latest selected filing: 10-Q · 2026-08-13

Annual financials

Annual flows and balances are grouped by their actual period end. Select a figure to open its SEC filing. A dash means a matching observation is unavailable.

Period ended2025-12-312024-12-312023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-31
Revenue$9.10M$9.09M$7.79M$8.18M$7.18M$7.13M$9.47M$11.09M$7.46M—
Cost of Revenue$4.03M$3.76M$3.18M$3.27M$2.94M$2.78M$3.93M$4.07M$2.12M$1.94M
Operating Income-$267.0K-$68.0K-$663.0K-$183.0K-$1.92M-$2.82M-$5.73M-$3.47M-$4.94M-$4.85M
Net Income-$418.0K-$209.0K-$131.0K-$331.0K-$899.0K-$2.72M-$4.26M-$2.13M-$6.07M-$1.08M
EPS (Diluted)$-0.05$-0.03$-0.02$-0.04$-0.11——$-0.33$-1.46$-0.34
Total Assets$4.82M$5.17M$5.39M$5.13M$4.95M$5.29M$6.62M$7.80M$6.86M$7.04M
Total Liabilities$4.58M$4.80M$5.28M$5.36M$5.23M$5.32M$5.21M$5.26M$4.80M—
Shareholders' Equity-$4.06M-$3.93M-$4.19M-$4.52M-$4.59M-$4.33M-$2.89M$2.54M$2.06M$3.44M
Cash & Equivalents————————$304.0K$110.0K
Operating Cash Flow$8.0K$13.0K$929.0K$332.0K-$1.30M-$341.0K-$1.40M-$1.08M-$2.14M—
Capital Expenditures$43.0K$166.0K$80.0K$1.0K$23.0K$28.0K$164.0K$185.0K$112.0K$231.0K
Shares Outstanding8.00M8.00M8.00M8.00M8.00M7.54M7.54M6.93M6.06M3.95M
Weighted Average Diluted Shares8.00M8.00M8.00M8.00M7.83M——6.39M4.16M3.19M
EPS (Basic)$-0.05$-0.03$-0.02$-0.04$-0.11——$-0.33$-1.46$-0.34